Cardiomyopathy is a leading cause of heart failure in children, and there are currently no effective treatments. Could emerging therapies that successfully target the root cause of the condition in adults also work well in children? That was the question Dr....
Pioneering use of CRISPR for upregulation of utrophin
Ground-breaking work underway using CRISPR
Using ExAC to reassess the pathogenicity of Mendelian disease genes in cardiomyopathy
ExAC used to reassess pathogenicity of Mendelian disease
Canada’s first cardiac precision medicine program
Deciphering the genetic code of pediatric heart disease